Also, these aspects have been studied using proteomic tools showing that these peptides have multi-target biological effects and inhibit enzymes such as dipeptidyl peptidase-IV (DPP-IV) and renin, which are involved in type 2 diabetes and hypertension, respectively. Here, DPP4 is linked to type 2 diabetes mellitus.